Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo F W Soeterik

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
JAMA Oncology|April 30, 2026
Local Salvage Therapy Alone for Local Recurrence of Prostate Cancer After Radiotherapy: A Systematic Review and Meta-AnalysisMarcin Miszczyk, Federico Mastroleo, Anna Kujawska, et al.
The Lancet. Oncology|February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort studyTimo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2024
The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysisTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Oncology|September 9, 2023
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging ParametersElio Mazzone, Giorgio Gandaglia, Daniele Robesti, et al.
European Urology Oncology|June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel ToolGiorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
European Urology Open Science|September 11, 2024
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional StudyRiccardo Leni, Emily A Vertosick, Roderick C N van den Bergh, et al.
European Urology Oncology|November 29, 2024
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical ProstatectomyTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 27, 2025
Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomyVera Sweere, Alexandra Bruins Slot, Rick Hermsen, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
JAMA Oncology|April 30, 2026
Local Salvage Therapy Alone for Local Recurrence of Prostate Cancer After Radiotherapy: A Systematic Review and Meta-AnalysisMarcin Miszczyk, Federico Mastroleo, Anna Kujawska, et al.
The Lancet. Oncology|February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort studyTimo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2024
The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysisTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Oncology|September 9, 2023
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging ParametersElio Mazzone, Giorgio Gandaglia, Daniele Robesti, et al.
European Urology Oncology|June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel ToolGiorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
European Urology Open Science|September 11, 2024
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional StudyRiccardo Leni, Emily A Vertosick, Roderick C N van den Bergh, et al.
European Urology Oncology|November 29, 2024
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical ProstatectomyTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 27, 2025
Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomyVera Sweere, Alexandra Bruins Slot, Rick Hermsen, et al.
Pageof 6